Skin checks reveal a high percentage of 'harmless' melanomas

FDA grants Breakthrough Therapy Designation to Reunion Neuroscience's RE104, a single-dose psychedelic treatment for postpartum depression showing 71% remission rates.

FDA's strict new 'healthy' label rules have triggered a 2026 food reformulation crisis. Manufacturers face ingredient shortages as they race to adapt.

Life Biosciences begins the first human trial of ER 100, a cellular rejuvenation therapy using epigenetic reprogramming to reverse vision loss.

ED and HHS launch a major 2026 partnership to consolidate family engagement and school safety programs, streamlining federal oversight under Secretaries McMahon and Kennedy.